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Abstract 
Background: Before discharging a patient from the ICU, an adequate patient evaluation is needed to detect indi-
viduals as high risk for unfavorable outcome. A pro- or anti-inflammatory status is a potential risk factor for an adverse 
outcome, and elevated CRP concentrations have shown to correlate with organ failure. Several studies have been 
performed to evaluate the use of CRP as a marker of post-ICU prognosis. Results are seemingly conflicting, and it is 
worthwhile to investigate these markers further as CRP is an adequate marker of pro- and anti-inflammatory status 
of the patient. We aimed to test the hypothesis that elevated CRP levels at ICU discharge are associated with an 
increased risk of ICU readmission and in-hospital mortality in patients with a prolonged ICU stay.
Methods: A retrospective cohort study was performed in a single-center hospital with an 18-bed mixed medical/
surgical ICU. Patients discharged alive from the ICU with at least 48-h ICU length of stay were evaluated. Patients were 
distributed into two groups: ‘high CRP’ (≥75 mg/L) and ‘low CRP’ (<75 mg/L) at ICU discharge. We assessed the differ-
ence in adverse outcome (ICU readmission and/or in-hospital mortality) between these groups.
Results: A total of 998 patients were included. Compared to the ‘low CRP’ group, patients in the ‘high CRP’ group 
had a higher readmission rate (13.1 vs. 7.4 %; p = 0.003). The post-ICU mortality rate in the ‘high CRP’ group and ‘low 
CRP’ group was 6.9 % and 4.7 %, respectively; p = 0.127. Combined readmission and mortality rates were significantly 
higher in the ‘high CRP’ group in comparison with the ‘low CRP’ group (17.9 vs. 10.1 %; p = 0.001). Hospital mortality in 
patients readmitted to the ICU was significantly higher than in non-readmitted patients (20 vs. 4.3 %; p < 0.001). Strik-
ingly, the ‘high CRP’ group had significantly lower APACHE II and SOFA scores at ICU admission compared to the ‘low 
CRP’ group. This highlights the potential for ICU-acquired risk factors, including CRP.
Conclusions: A high CRP concentration (≥75 mg/L) within 24 h before ICU discharge is associated with an increased 
risk of adverse outcome post-ICU discharge. However, CRP at discharge represents only a very moderate risk factor 
and may not be used for individual clinical decision-making.
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Background
To discharge a patient from the intensive care unit (ICU) 
to another hospital ward is a complex decision-making 
process [1]. On the one hand, unnecessarily prolonged 
ICU stay is unwanted. On the other hand, prema-
ture discharge from ICU has potential hazards, such as 
readmission or death [2]. Therefore, an adequate evalu-
ation of the patient before ICU discharge is necessary 
to detect individuals as high risk for unfavorable out-
comes, using clinical predictors and objective param-
eters, by which readmission to ICU and in-hospital 
mortality can be reduced [3]. Available scoring sys-
tems such as the Acute Physiology and Chronic Health 
Evaluation (APACHE), the Simplified Acute Physiol-
ogy Score (SAPS) and the Sequential Organ Failure 
Assessment (SOFA) scores are not designed to evaluate 
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ICU-discharge risk factors [4–6]. In addition, it is con-
ceivable that attributable risk factors may exist as a result 
of the course of the disease during ICU stay or individual 
patient response to disease- or ICU-related insults [7].
A potential risk factor at ICU discharge is the pro- or 
anti-inflammatory status of the patient. Easily accessible 
markers of these processes are body temperature, leuko-
cyte count and C-reactive protein (CRP) levels. CRP con-
centrations correlate with ongoing organ dysfunction and 
ICU mortality [8]. This marker is routinely measured at 
ICU and has advantages of simplicity, reproducibility and 
speed [9].
Several studies have been performed to predict in-hos-
pital mortality and readmission after ICU discharge in 
relation to signs of inflammation [10–14]. Because these 
results are seemingly conflicting, there is no evident 
point of view about the ability to use serum CRP concen-
tration as a marker of post-ICU prognosis. In addition to 
this, the aforementioned studies have been criticized for 
their small sample sizes [10, 12, 15] and the selection of a 
patient population with a relatively good prognosis [12, 
14].
The primary objective in this study was to test the 
hypothesis that elevated CRP levels at ICU discharge are 
associated with adverse outcome (ICU readmission and 
in-hospital mortality) in patients with a prolonged ICU 
stay (>48  h) and an anticipated attributable death rate 
post-ICU.
Methods
This is a single-center retrospective cohort study of 
critically ill patients admitted to the ICU of the Medical 
Center Leeuwarden (MCL) in the Netherlands. Accord-
ing to applicable laws, the need for informed consent was 
waived by the regional ethical committee (Regionale Toe-
tsingscommissie Patientgebonden Onderzoek, RTPO), 
due to the strict observational design of this study, using 
a database setup with clinical features of patients admit-
ted to the ICU over the past 10  years. The ICU of the 
MCL is a closed format department and has 18 intensive 
care beds and four high care beds. Both medical and sur-
gical patients are admitted to the department, includ-
ing cardiothoracic patients. Long-stay ICU patients are 
discharged on weekdays during office hours, with little 
to no discharges in out-of-office hours. Patients are dis-
charged from the ICU, when the intensivist decides they 
no longer require ICU-specific treatment for organ dys-
function, and their condition appears stable enough to be 
managed with low-intensity nursing care.
Patients who were discharged alive from the ICU with 
an ICU length of stay (LOS) >48 h were included in the 
study. For patients with multiple ICU admissions, only 
the first admission was included. Exclusion criteria were 
patients younger than 18  years of age, missing CRP 
data at discharge or loss to follow-up due to transfer to 
another hospital. The database analyzed in this study 
included details of ICU admissions between 2009 and 
2012. Clinical predictors analyzed included demograph-
ics (age and sex), comorbidities, diagnosis group at 
admission and type of admission. The clinical predic-
tors analyzed included severity of illness APACHE II [4], 
standardized mortality rate (SMR), SOFA [5] and SAPS 
II [6], days of mechanical ventilation and use of renal 
replacement therapy (continuous veno-venous hemo-
filtration, CVVH). APACHE II, SAPS II score and SMR 
were determined on the day of admission. The SOFA was 
daily calculated during ICU stay. Also, the LOS in hospi-
tal before ICU admission, the patient’s admission source 
(from the emergency department, transfer from a ward, 
or from the operating room), LOS during the ICU period, 
the destination after ICU discharge (to the ward, to a 
nursing home or to home), LOS after primary ICU dis-
charge and mortality or ICU readmission were recorded.
 Serum CRP and white cell count (WCC) were rou-
tinely measured every morning during the complete 
ICU stay. Serum CRP was measured by a latex-mediated 
immunoturbidimetric method in plasma heparin, using 
a modular analyser (Roche Diagnostics, Mannheim, 
Germany), and WCC was measured in dipotassium eth-
ylenediamine tetraacetic acid (EDTA) blood with a hema-
tologic analyser (Abbot Laboratories, Santa Clara, CA, 
USA). Body temperature was measured at least every 8 h 
via internal ear. We extracted the following data at ICU 
admission and on the day of discharge: CRP, WCC and 
body temperature.
Patients were divided in two predefined subgroups: 
‘high CRP’ at ICU discharge: CRP ≥75  mg/L and ‘low 
CRP’ at ICU discharge: CRP <75 mg/L, according to pre-
vious reports [16]. The primary endpoint of this study 
was adverse outcome. We defined adverse outcome as 
readmission to the ICU, and/or death on the ward after 
ICU discharge. Readmission was defined by discharge 
to an area that provided a lower level of care followed 
by return to the same ICU within the same hospitaliza-
tion period. Post-ICU death is defined by death after ICU 
discharge within the same hospitalization; this included 
patients who died during their readmission on the ICU. 
In a secondary analysis of unfavorable outcome, we 
excluded all planned ICU readmissions and patients who 
were discharged from the ICU with ‘do-not-resuscitate’ 
orders in combination with limitation of future therapeu-
tic interventions, and subsequently died in ward.
For statistical analysis, the statistical package for social 
science (SPSS 16 for Windows; SPSS Inc, Chicago, IL, 
USA) was used. Using the Kolmogorov–Smirnov test, 
data were tested for normal distribution. For continuous 
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variables, normal distributed data are presented as 
mean  ±  standard deviation (SD), non-normal distrib-
uted data as median with 25th and 75th percentiles 
(interquartile range, IQR). Categorical variables are pre-
sented as percentage (%). Baseline characteristics and 
laboratorial data of both groups (CRP ≥75  mg/L and 
CRP <75  mg/L) are compared using the nonparametric 
Mann–Whitney U test or unpaired t test. All statistics 
were two-tailed, and a p value <0.05 was considered sta-
tistically significant. A multivariate logistic regression 
was used to identify variables independently associated 
with adverse outcome. All factors associated with adverse 
outcome with a p value ≤0.25 in univariate analysis were 
included. The model was refined in a backward stepwise 
manner, excluding at each step the least significant of any 
variables not significant at p < 0.05. Therefore, variables 
were tested at nonlinearity of the logit and multicolline-
arity. Hosmer–Lemeshow goodness-of-fit tests were per-
formed to access the calibration of the new model. Also, 
CRP and discrimination of the model were tested to pro-
duce receiver operating characteristic (ROC) curves, in 
accordance with Ray et al. [17]. The area under the curve 
(AUC) with 95 % confidence interval (CI) was calculated 
in prediction of patient’s adverse outcome. The optimal 
cutoff value of CRP was defined as the value associated 
with the highest sum of sensitivity and specificity −1 
(Youden index).
Results
Out of 1239 patients with an ICU stay >48 h, a total of 
1033 were discharged alive from the ICU between Sep-
tember 2009 and September 2012. Flowchart is shown 
in Fig.  1. After exclusions, 998 patients were available 
for primary analysis. Median age was 66 [65–74] and 
median APACHE II score 19 [15–24]. Baseline charac-
teristics, type of admission and diagnostic subgroups 
are presented in Table 1. The overall in-hospital mortal-
ity rate was 5.5 % (n = 55), and the overall readmission 
rate was 9.5 % (n = 95). Out of 998 patients discharged 
alive from ICU, a total of 375 had CRP levels ≥75 mg/L 
(‘high CRP’) and 623 had CRP levels <75  mg/L (‘low 
CRP’). The ‘high CRP’ group, in comparison with the 
‘low CRP’ group, had a significant lower SOFA score 
at ICU admission (6.7 ±  2.9 vs. 7.5 ±  2.9; p  <  0.001), a 
lower APACHE II score at ICU admission (18 [14–22] 
vs. 19 [15–25]; p < 0.001) and a lower CRP value at ICU 
admission (57 [7–170] vs. 72 [15–180]; p = 0.046). Fur-
thermore, these patients were more likely to be admit-
ted for planned surgery (42 vs. 25 %; p < 0.001, Table 1). 
The ‘low CRP’ group was treated more often with renal 
support (17 vs. 9 %; p < 0.001) and had a longer LOS in 
ICU (9 [6–16] vs. 6 [4–8]; p < 0.001, Table 2). Patients in 
the ‘high CRP’ group had a readmission rate of 13.1 %. In 
the ‘low CRP’ group, this was 7.4 %; p = 0.003. The post-
ICU mortality rate in the ‘high CRP’ group and ‘low CRP’ 
group was 6.9 % and 4.7 %, respectively; p = 0.127. The 
adverse outcome rate was significantly higher in the ‘high 
CRP’ group in comparison with the ‘low CRP’ group 
(17.9 vs. 10.1 %; p = 0.001). Hospital mortality in patients 
readmitted to the ICU was significantly higher than in 
the non-readmitted patients (20 vs. 4.3  %; p  <  0.001). 
Eighty-five percentage of non-elective readmissions were 
related to the index admission. Median number of days 
to readmission was 3 [2–5] and not statistically different 
between groups (Table  3). In a secondary analysis, we 
furthermore excluded 11 electively readmitted patients 
(primarily for scheduled surgery) and 27 patients with 
therapeutic restriction orders. Outcomes variables are 
demonstrated in Table 4.
In a univariate analysis of all patients, female sex, 
age, APACHE II score, type of admission, CRP group 
(≥75 mg/L), temperature at discharge, SOFA score at dis-
charge, LOS in ICU and use of renal support were fac-
tors associated with adverse outcome and included for 
further analysis. Multivariate logistic regression analysis 
showed that age, temperature at discharge, SOFA score 
Fig. 1 Flowchart
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at discharge, medical admission type, female sex and CRP 
≥75 mg/L at discharge were significantly associated with 
adverse outcome (Table 5).
In a post hoc analysis, a ROC curve was constructed for 
both CRP value at discharge, CRP group combined with 
other variables (model 1) and this model without CRP 
group (model 2). Results are shown in Fig.  2. The opti-
mal cutoff (Youden index) for unfavorable outcome was 
at a CRP level of 72 mg/L, with a sensitivity of 57 % and a 
specificity of 62 %. Model 1 showed an area under curve 
of 0.66 (95 % CI 0.61–0.71; p < 0.001). Therewithal, the 
model was rather calibrated in both cohorts of patients 
Table 1 Baseline characteristics
Data are presented as mean ± SD (normal distribution), as median with interquartile range (non-normal distribution) or as % (categorical variable)
CRP C-reactive protein; high CRP, CRP ≥75 mg/L; low CRP, CRP <75 mg/L; LOS length of stay; APACHE II, Acute Physiology and Chronic Health Evaluation II; SMR 
standardized mortality rate; SOFA Sequential Organ Failure Assessment; SAPS II Simplified Acute Physiology Score II; WCC white cell counts; Temp body temperature; 
COPD chronic obstructive pulmonary disease; CFH congestive heart failure
All (n = 998) ‘High CRP’ (n = 375) ‘Low CRP’ (n = 623) p value
Age (years) 66 [56–74] 66 [56–75] 66 [56–74] 0.349
Male sex (%) 62 61 62 0.924
LOS in hospital before ICU admission 1 [0–4] 1 [1–4] 1 [0–4] 0.655
APACHE II score admission 19 [15–24] 18 [14–22] 19 [15–25] <0.001
SMR score admission 27 [12–53] 21 [10–41] 32 [14–57] <0.001
SOFA score admission 7.2 (2.9) 6.7 (2.9) 7.5 (2.9) <0.001
SAPS II score admission 32 [26–39] 31 [25–38] 33 [26–42] 0.048
CRP admission (mg/L) 66 [10–178] 57 [7–170) 72 [15–180] 0.046
WCC admission (×109) 13.8 (8.2) 13.0 (6.9) 14.2 (8.9) 0.032
Temp admission (°C) 37.2 (1.2) 37.2 (1.1) 37.3 (1.3) 0.144
Comorbidities (%)
 Chronic renal failure 8 8 7 0.485
 Hypertension 30 31 29 0.552
 COPD 20 20 19 0.620
 Diabetes mellitus 19 18 20 0.394
 Chronic cardiovascular disease 18 18 18 0.781
 Cancer 15 14 15 0.597
 Other 6 6 7 0.534
Diagnosis group (%)
 Elective surgery 12 20 8
 Cardiac surgery 26 31 23
 Sepsis 38 32 41
 Trauma 2 2 2
 Cardiac arrest 8 7 9 <0.001
 CFH 5 3 6
 COPD 2 1 2
 Intoxication 2 1 2
 Metabolic 1 1 2
 Others 4 3 5
Type of admission (%)
 Medical 43 31 50
 Surgical—planned 31 42 25 <0.001
 Surgical—urgent 26 27 25
Patient’s origin (%)
 Emergency department 23 20 25
 Ward 19 12 23 <0.001
 Operating room 54 66 47
 Other hospital 4 2 5
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(Hosmer–Lemeshow goodness-of-fit test: Chi-square, 
14.4; p = 0.07).
Discussion
In this retrospective cohort study with 998 patients 
discharged alive from the ICU and an ICU stay >48  h, 
we evaluated the relation between CRP levels at ICU 
discharge and ICU readmission and post-ICU mortality. 
Our data demonstrate that adverse outcome (ICU read-
mission and/or post-ICU mortality) was significantly 
increased in the ‘high CRP’ (CRP ≥75  mg/L) group in 
comparison with ‘low CRP’ (CRP <75 mg/L) group. This 
effect was particularly seen in relation to an increased 
risk of ICU readmission. A ‘high CRP’ at discharge was 
Table 2 Primary and secondary outcomes
Data are presented as mean ± SD (normal distribution), as median with interquartile range (non-normal distribution) or as % (categorical variable)
CRP C-reactive protein; high CRP, CRP ≥75 mg/L; low CRP, CRP <75 mg/L; adverse outcome, intensive care unit readmission and/or in-hospital mortality; WCC white 
cell counts; Temp body temperature; SOFA Sequential Organ Failure Assessment; LOS length of stay; ICU intensive care unit
All (n = 998) ‘High CRP’ (n = 375) ‘Low CRP’ (n = 623) p value
Readmission (%) 9.5 13.1 7.4 0.003
In-hospital mortality (%) 5.5 6.9 4.7 0.127
Adverse outcome (%) 13.4 17.9 10.1 0.001
CRP discharge (mg/L) 58 [33–102] 115 [93–161] 39 [19–55] <0.001
WCC discharge (×109) 12.4 (5.7) 13.3 (5.7) 11.9 (5.6) <0.001
Temp discharge (°C) 37.1 (1.3) 37.2 (1.1) 37.0 (1.4) 0.068
SOFA score discharge 3.0 (1.8) 3.3 (1.9) 2.9 (1.7) <0.001
LOS ICU (days) 7 [5–12] 6 [4–8] 9 [6–16] <0.001
Mechanical ventilation (%) 94 95 93 0.233
Days of mechanical ventilation (n) 3 [1–6] 2 [1–4] 4 [1–7] <0.001
Renal support (%) 14 9 17 <0.001
Destination (%)
 Ward 96 99 95
 Home 1 0 1 0.004
 Nursing/rehabilitation center 3 1 4
LOS hospital after ICU discharge (days) 9 [5–16] 9 [6–16] 9 [5–16] 0.404
Table 3 Readmission
Data are presented as median with interquartile range (non-normal distribution) or as % (categorical variable)
CRP C-reactive protein; high CRP, CRP ≥75 mg/L; low CRP, CRP <75 mg/L
All (n = 95) ‘High CRP’ (n = 49) ‘Low CRP’ (n = 46) p value
Reason for readmission (%)
 Sepsis 4 2 2
 Non-sepsis 4.5 2 2 0.902
 Elective 1 0.5 0.5
Days between discharge and readmission (n) 3 [2–5] 3 [2–5] 3 [3–6] 0.785
Table 4 Outcome after exclusion ‘planned ICU readmissions’ and ‘restriction orders’
Data are presented as  %
ICU intensive care unit; CRP C-reactive protein; high CRP, CRP ≥75 mg/L; low CRP, CRP <75 mg/L; adverse outcome, intensive care unit readmission and/or in-hospital 
mortality
All (n = 961) ‘High CRP’ (n = 358) ‘Low CRP’ (n = 602) p value
Readmission (%) 8.7 12.3 6.6 0.003
In-hospital mortality (%) 2.9 3.6 2.5 0.308
Adverse outcome (%) 10.1 14 7.8 0.002
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not significant related with post-ICU mortality alone. 
However, readmission to the ICU was associated with an 
almost fivefold increase in in-hospital mortality. These 
results were similar after excluding planned readmis-
sions and patients with therapeutic restriction orders, 
who subsequently died in the hospital ward. A potential 
explanation could be the previous-described association 
between a state of persistent inflammation in survivors 
of an acute infection and deterioration of other diseases, 
such as cardiovascular disease, thus increasing long-term 
mortality [18]. However, our study was not designed to 
explore a potential causative relationship between (per-
sistent) inflammation during critical illness and adverse 
outcome.
Although significant, CRP values at discharge would 
represent only a poor risk factor in the prediction of 
adverse outcome, with an area under the ROC curve 
of 0.58. Subsequent inclusion of age, female sex, SOFA 
score at discharge, temperature at discharge and medical 
admission type to a multivariate logistic regression anal-
ysis-based model provided a better predictor of adverse 
outcome. However, after excluding CRP value at discharge 
from this model, there was no significant difference in 
AUC, which means that adding CRP value to this predic-
tive model poorly improves the ability to predict adverse 
outcome. It is of note that the APACHE II score at admis-
sion was excluded from the logistic regression analysis, 
despite its well-known overall predictive value for ICU and 
hospital mortality. This underlines the need for predic-
tive models at ICU discharge that specifically take ICU-
derived variables into consideration, such as the impact of 
therapy (e.g., renal replacement) and the patient response 
Table 5 Multivariate analysis of  factors associated 
with adverse outcome
Hosmer–Lemeshow goodness-of-fit test: Chi-square, 14.4; p = 0.07
Adverse outcome, intensive care unit readmission and/or in-hospital mortality
Temp body temperature, SOFA Sequential Organ Failure Assessment, CRP 
C-reactive protein
Odds ratio [95 % CI] p value
Age 1.02 [1.01–1.03] 0.018
Temp at discharge 1.59 [1.05–2.41] 0.028
SOFA score at discharge 1.21 [1.10–1.34] <0.001
Medical admission 1.75 [1.18–2.58] 0.005
Female sex 1.50 [1.03–2.19] 0.035
CRP at discharge ≥75 mg/L 1.69 [1.14–2.50] 0.009
Fig. 2 ROC curves of CRP concentrations at ICU discharge alone, CRP group combined with other covariates (model 1) and this model without 
CRP group (model 2), to discriminate between good outcome and adverse outcome after ICU discharge. CRP value at ICU discharge: area under the 
ROC curve: 0.58, 95 % CI 0.54–0.63; p = 0.002. Model 1: area under the ROC curve: 0.66, 95 % CI 0.61–0.71; p < 0.001. Model 2: area under the ROC 
curve: 0.65, 95 % CI 0.60–0.70; p < 0.001. ROC receiver operating characteristics, CRP C-reactive protein, ICU intensive care unit; adverse outcome: ICU 
readmission and/or in-hospital mortality, SOFA Sequential Organ Failure Assessment, CI confidence interval
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to the primary insult and therapy (e.g., CRP). This is also 
reflected by the fact that patients, discharged with a ‘high 
CRP,’ had lower CRP values and lower severity of illness 
scores at ICU admission, as compared to patients dis-
charged with a ‘low CRP.’ Moreover, these patients had 
received less intense ICU care (days of mechanical venti-
lation and renal replacement therapy) and a shorter ICU 
stay. This may reflect the importance of ICU-acquired risk 
factors and a different inflammatory response in this spe-
cific patient group. Alternatively, the higher CRP values 
are a marker of earlier ICU discharge in comparison with 
patients who are admitted seemingly more ill.
Important differences of our data with previous stud-
ies are the selection of patients with a prolonged ICU 
stay (>48  h), with a concomitant higher likelihood of 
adverse. Secondly, we defined a composite primary out-
come measure, consisting of both in-hospital mortality 
and ICU readmission. Finally, we a priori divided our 
groups into ‘high CRP’ and ‘low CRP,’ instead of out-
come variables. Based on previous studies, we defined 
the CRP cutoff point at 75  mg/L. Post hoc the Youden 
index of the ROC curve showed a CRP level of 72 mg/L 
as the optimal cutoff point for adverse outcome, thus 
confirming our assumptions. However, this cutoff point 
has a weak sensitivity and specificity. Silvestre et al. [15] 
divided groups based on CRP value. However, this was a 
post hoc analysis after a primary analysis based on out-
come. In accordance with our data, no correlation was 
found between CRP at discharge and post-ICU mortal-
ity, but no link was made between CRP and ICU read-
mission. Furthermore, their sample size was more than 
sixfold smaller than ours. In accordance with our study, 
Al Subaie et  al. [14] investigated discharge CRP values 
and adverse outcome: readmission and in-hospital mor-
tality, separately and together. All independent groups 
did not show a significant difference between discharge 
CRP and adverse outcome, in contrast to our results. 
Sample sizes of both studies were similar (1185 vs. 998), 
and the unplanned readmission rate in the paper of Al 
Subaie et al. was comparable (7 vs. 8.7 %) with identical 
unexpected death rates (2.9  %). However, median LOS 
ICU (1.8 days), APACHE II scores (16) and percentage of 
patients on mechanical ventilation (51 %) were consider-
ably lower to our data, suggesting a significantly different 
patient population.
Our finding that discharge CRP was not associated 
with in-hospital mortality alone does not seem to be 
in line with the results of Ho et  al. [11]. They found in 
their study with 603 patients that CRP at ICU discharge 
independently predicted subsequent death in hospital. 
Their study population was similar in its mixed surgi-
cal/medical nature, but CRP values were not available 
for all patients (only 73 % in non-survivors and 71 % in 
survivors), since this was not part of the standard meas-
urements. Such non-random missing data create the pos-
sibility of a selection bias.
This study has several limitations. Firstly, this was a 
retrospective and single-center analysis, thus subject-
ing to biases. We do not know whether our findings can 
be extrapolated to other ICUs. Particularly, the specific 
logistics of ICU discharge in our hospital may be of criti-
cal importance in this respect. Secondly, by nature of 
our study design, a cause–effect relationship between a 
pro-inflammatory status and adverse outcome cannot 
be established. Despite elimination of many confounders 
by means of multivariate logistic regression analysis, the 
possibility of elevated CRP concentrations as a marker 
of a different unknown process cannot be excluded. In 
this respect, it is also conceivable that the routine use 
of daily CRP measurements in our ICU might have 
influenced clinical decision-making, including ICU dis-
charge. Thirdly, a mixed group of medical and surgical 
patients were included; whether CRP will have a differ-
ent performance in a particular subgroup of patients 
deserves further investigation. Finally, the AUC of both 
CRP level and the constructed model do not allow clini-
cians to make decisions with respect to ICU discharge 
on an individual patient bases. However, the presence of 
a combination of risk factors, as used in our model, may 
cause awareness of doctors for attributable morbidity 
and mortality post-ICU in individual patients. Whether 
interventions, such as postponement of ICU discharge 
or additional diagnostic/therapeutic procedures may 
reduce unfavorable outcome, remains to be established 
in future studies.
Conclusions
In conclusion, this large retrospective cohort of critically 
ill patients (ICU LOS >48  h) in a mixed medical/surgi-
cal ICU substantiated the hypothesis that elevated CRP 
levels at ICU discharge are associated with readmission 
and in-hospital mortality. However, CRP at discharge 
represents only a very moderate risk factor and may not 
be used for individual clinical decision-making.
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